Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10096-2 | ZM-447439 | LSM-1096 | 9914412 | ||
10348-1 | Z-Leu-Leu-Norvalinal | MG-115 | LSM-6358 | 9868928 | |
10275-1 | (Z)-4-Hydroxytamoxifen | LSM-43294 | 53770298 | ||
10283-1 | XRP44X | AG-G-87906 | LSM-4298 | 10339779 | |
10282-1 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 | 5311 | |
10281-1 | Vinorelbine | Navelbine | LSM-6302 | 5311497 | |
10346-1 | Valproic acid | Depakine | LSM-4620 | 3549980 | |
10280-1 | Triciribine | LSM-3810 | 65399 | ||
10279-1 | Trichostatin A | LSM-43005 | |||
10142-2 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 | 11707110 | |
10136-2 | TPCA-1 | LSM-1136 | 9903786 | ||
10021-5 | Tozasertib | VX680; MK-0457 | LSM-1021 | 5494449 | |
10345-3 | Torkinib | PP242 | LSM-6357 | 57347681 | |
10278-1 | Topotecan | Hycamtin | LSM-5662 | 60700 | |
10277-1 | Temsirolimus | LSM-4295 | 148191 | ||
10520-1 | TCS PIM-1 1 | 1235170 | |||
10276-1 | TCS 2312 | LSM-6362 | 11258443 | ||
10102-3 | Taxol | Paclitaxel | LSM-1102 | 441276 | |
10175-3 | Sunitinib | Sutent; SU11248 | LSM-42800 | 3086686 | |
10008-3 | Sorafenib | BAY-439006 | LSM-1008 | 216239 | |
10052-3 | Sirolimus | Rapamycin | LSM-1052 | 5040 | |
10035-2 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 | 10196499 | |
10056-2 | Selumetinib | AZD6244; Array142886 | LSM-1056 | 10127622 | |
10274-1 | SB-3CT | LSM-4293 | 9883002 | ||
10516-1 | Ribavirin | Tribavirin | 37542 |